High-frequency oscillatory ventilation (HFOV) may reduce the incidence of bronchopulmonary dysplasia (BPD) compared with conventional mechanical ventilation (CMV) in infants born at 34 weeks’ ...

Neonatal respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in preterm infants. This condition stems primarily from an insufficiency in pulmonary surfactant, a ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

High-frequency oscillatory ventilation (HFOV) reduced bronchopulmonary dysplasia in preterm infants with neonatal respiratory ...

China: Researchers have found in a new study that pulmonary surfactant (PS) therapy significantly improves arterial blood gas parameters and clinical symptoms in infants with neonatal respiratory ...

High-Frequency Oscillation vs Mechanical Ventilation for Neonatal Acute Respiratory Distress Syndrome 1. High-frequency ...

In a recent study published in Nature Communications, researchers investigate the risk of respiratory distress (RD) in neonates born to mothers with severe acute respiratory syndrome coronavirus 2 ...

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed ...

Prenatal exposure to air pollution increases the risk of severe respiratory distress in newborn babies, according to new research. The risk increases with exposure specifically to fine particulate ...

Advent Therapeutics is developing vitamin A therapies aimed at preventing chronic lung disease in premature babies.